Measuring Cognition in Oncology Trials
December 22, 2015
The third entry in Cogstate’s podcast series on measuring cognition in clinical trials focuses on cognitive measures specifically in oncology trials. Dr. Brian Harel, Clinical Science Director at Cogstate and Assistant Clinical Professor at the Yale University School of Medicine, Child Study Center, discusses the methodologies used to measure cognition in oncology trials, as well as how the Cogstate battery of tests can be deployed in the gathering of this increasingly important data. He also elaborates on several leading cancer research collaborations and consortia with which Cogstate enjoys meaningful and important partnerships.
